- Home
- SPAI vs ANEB Comparison
SPAI vs ANEB Comparison
Compare SPAI & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPAI
- ANEB
- Stock Information
- Founded
- SPAI 2021
- ANEB 2020
- Country
- SPAI United States
- ANEB United States
- Employees
- SPAI N/A
- ANEB N/A
- Industry
- SPAI Industrial Specialties
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- SPAI Health Care
- ANEB Health Care
- Exchange
- SPAI Nasdaq
- ANEB Nasdaq
- Market Cap
- SPAI 139.4M
- ANEB 111.8M
- IPO Year
- SPAI 2024
- ANEB 2021
- Fundamental
- Price
- SPAI $4.31
- ANEB $2.31
- Analyst Decision
- SPAI Strong Buy
- ANEB Buy
- Analyst Count
- SPAI 3
- ANEB 2
- Target Price
- SPAI $10.00
- ANEB $8.00
- AVG Volume (30 Days)
- SPAI 258.2K
- ANEB 15.2K
- Earning Date
- SPAI 11-14-2025
- ANEB 11-13-2025
- Dividend Yield
- SPAI N/A
- ANEB N/A
- EPS Growth
- SPAI N/A
- ANEB N/A
- EPS
- SPAI N/A
- ANEB N/A
- Revenue
- SPAI $1,266,756.00
- ANEB N/A
- Revenue This Year
- SPAI N/A
- ANEB N/A
- Revenue Next Year
- SPAI $538.54
- ANEB N/A
- P/E Ratio
- SPAI N/A
- ANEB N/A
- Revenue Growth
- SPAI N/A
- ANEB N/A
- 52 Week Low
- SPAI $1.47
- ANEB $0.80
- 52 Week High
- SPAI $9.16
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- SPAI 34.12
- ANEB 34.78
- Support Level
- SPAI $4.15
- ANEB $2.32
- Resistance Level
- SPAI $5.13
- ANEB $2.39
- Average True Range (ATR)
- SPAI 0.49
- ANEB 0.09
- MACD
- SPAI -0.10
- ANEB -0.03
- Stochastic Oscillator
- SPAI 5.81
- ANEB 13.64
About SPAI Safe Pro Group Inc. Common Stock
Safe Pro Group Inc operates to acquire security and protection products. Its emphasis is on the development of a cloud-based ecosystem for analyzing drone imagery and data utilizing proprietary artificial intelligence (AI), machine learning, deep learning, and applied computer vision software for hyper-scalable processing, analysis, and reporting. The company operated in three reportable business segments which consisted of: the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. Key revenue is generated from Airborne Response.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.